Randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of BIIB074 in subjects with lumbosacral radiculopathy neuropathic pain
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: CONVERGENCE PHARMACEUTICALS LIMITED
- Phase: II
- Execution start: 20/04/2017
- End of execution: 30/05/2018
- PI: RAFAEL GALVEZ MATEOS